clinical

ALS Clinical

Approved for sale in Europe, CE Registration #518356 .

"US Investigational Device, not currently available for sale in the US .

Initial study of the device in ALS provided the feasibility of using diaphragmic pacing to slow the decline in a patient's Forced Vital Capacity and delay the onset of respiratory failure. Data from our pilot study revealed the average pre-implant rate of decline was calculated at -2.8% per month and for patients with at least 9 months post-implant follow-up the rate improved to
-1.0% per month.

We are also investigating to determine if the NeuRx DPS™ may be effective in ventilatory support of patients with ALS either decreasing or eliminating the need for negative or positive pressure mechanical ventilation.

Read testimonials from patients just like you.

Download the ALS Patient/Caregiver Brochure [PDF]

View ALS Patient/Caregiver Video

Or for information about the open ALS clinical trial please contact:

Study Hospital Name Coordinators

#1

University Hospitals of Cleveland
Cleveland, OH 44106
Mary Jo Elmo, ACNP
Office (216) 844-8594
maryjo.elmo@uhhs.com
#2 Johns Hopkins University
Baltimore, MD 21287
Laura Clawson-Research Coordinator
Office (410) 955-8511
lclawson@jhmi.edu
#3 Stanford University
Stanford, CA 94305
Shirley Paulose-Research Assistant, Neurology
Office (650) 724-3792
spaulose@stanford.edu
#4 Methodist Neurological Institute
Houston, Texas 77030
Luis F. Lay, Jr.-Senior Research Coordinator
Office (713) 441-3057
LFLayJr@tmhs.org
#5 Henry Ford Health System
Detroit, MI. 48202
Helen Foley-Research Coordinator
Office (313) 916-3955
helen@neuro.hfh.edu
#6 Mayo Clinic
Jacksonville, FL 32224
Karen Overstreet-ALS Research Coordinator
Office (904) 953-8946
Overstreet.Karen@mayo.edu
#7 California Pacific Medical Center (CPMC)
San Francisco, CA 94115
Dallas Forshew-Manager, ALS Research  
Office (415)600-3604
forshed@cpmcri.org